Literature DB >> 15451925

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation.

Giovanni Targher1, Lorenzo Bertolini, Roberto Padovani, Luciano Zenari, Giacomo Zoppini, Giancarlo Falezza.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15451925     DOI： 10.2337/diacare.27.10.2498

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  58 in total

1.  Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis.

Authors:  Jia Cai; Shujun Zhang; Wenxiang Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging.

Authors:  Roy Irwan; Mireille A Edens; Paul E Sijens
Journal:  Eur Radiol       Date:  2007-11-13       Impact factor: 5.315

Review 3.  Nonalcoholic fatty liver disease and cardiovascular disease risk.

Authors:  Roger K Schindhelm; Michaela Diamant; Robert J Heine
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

Review 4.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

Review 5.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Authors:  Ryan L McKimmie; Kurt R Daniel; J Jeffrey Carr; Donald W Bowden; Barry I Freedman; Thomas C Register; Fang-Chi Hsu; Kurt K Lohman; Richard B Weinberg; Lynne E Wagenknecht
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

7.  Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Michel Chonchol; Lorenzo Bertolini; Stefano Rodella; Luciano Zenari; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

8.  Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease.

Authors:  Cemal Nuri Ercin; Teoman Dogru; Serkan Tapan; Yildirim Karslioglu; Cem Haymana; Selim Kilic; Alper Sonmez; Zeki Yesilova; Ahmet Uygun; Mustafa Gulsen; Sait Bagci; M Kemal Erbil
Journal:  Dig Dis Sci       Date:  2009-05-14       Impact factor: 3.199

9.  Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.

Authors:  Guldem Kilciler; Halil Genc; Serkan Tapan; Fatih Ors; Muammer Kara; Nuri Karadurmus; C Nuri Ercin; Yildirim Karslioglu; Selim Kilic; Sait Bagci; M Kemal Erbil; Teoman Dogru
Journal:  Ups J Med Sci       Date:  2010-08-23       Impact factor: 2.384

Review 10.  Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.

Authors:  Gianluca Perseghin
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.